The orphan receptors Rev-erbα and Rev-erbβ are members of the nuclear receptors superfamily and act as transcriptional repressors. Rev-erbα is expressed with a robust circadian rhythm and is involved in liver metabolism through repression of the ApoA1 gene, but no role has been yet defined for Rev-erbβ. To gain better understanding of their function and mode of action, we characterized the proteins encoded by these two genes. Both Rev-erbα and Rev-erbβ proteins were nuclear when transiently transfected in COS-1 cells. The major nuclear location signal (NLS) of Rev-erbα is in the amino-terminal region of the protein. Fusion of green fluorescent protein (GFP) to the amino terminus of Rev-erbα deletion mutants showed that the NLS is located whithin a 53 amino acid segment of the DNA binding domain (DBD). The homologous region of Rev-erbβ fused to GFP also targeted the fusion protein to the nucleus, suggesting that the location of this NLS is conserved among all the Rev-erb group members. Interestingly, members of the phylogenetically closest nuclear orphan receptor group (ROR), which exhibit 58% amino acid identity with Rev-erb in the DBD, do not have their NLS located whithin the DBD. GFP/DBD.RORα or GFP/DBD.RORβ remained cytoplasmic, in contrast to GFP/DBD.Rev-erb fusion proteins. Alignment of human Rev-erb and ROR DBD amino acid sequences predicted that the two basic residues, K167 and R168, located just upstream from the second zinc finger, could play a critical part in the nuclear localization of Rev-erb proteins. Substitution of these two residues with those found in ROR, in the GFP/DBD.Rev-erb context, resulted in cytoplasmic proteins. In contrast, the reverse mutation of the GFP/DBD.RORα towards the Rev-erbα residues targeted the fusion protein to the nucleus. Our data demonstrate that Rev-erb proteins contain a functional NLS in the DBD. Its location is unusual within the nuclear receptor superfamily and suggests that Rev-erb orphan receptors control their intracellular localization via a mechanism different from that of other nuclear receptors.
Introduction
Nuclear hormone receptors have an important role in cellular regulation, providing a direct link between extracellular hormonal signals and transcriptional responses (Laudet & Gronemeyer 2002) . These molecules are ligand-activated transcription factors that regulate the expression of target genes by binding to specific cis acting sequences (Mangelsdorf et al. 1995) . The superfamily includes receptors for steroid hormones, retinoic acid, thyroid hormone, vitamin D and fatty acids. In most cases, nuclear receptors are inducible transcriptional activators, which actively repress transcription of their target genes in the absence of hormone and activate transcription upon ligand binding. All nuclear receptors share the same overall protein organization with several independent functional domains. In the N-terminal domain (A/B domain), a hormone-independent transactivation function (AF1 region) has been identified in many receptors such as thyroid hormone receptors (TR, NR1A in the official nomenclature, see Nuclear Receptors Nomenclature Committee 1999) or steroid receptors (NR3C) (Laudet & Gronemeyer 2002) . Immediately downstream, the highly conserved C domain, a sequence signature of the superfamily, is responsible for both specific DNA binding and dimerization. Although also participating to some extent in the DNA binding function, the D domain is mainly considered as a flexible hinge region between the DNA binding domain (DBD) and the C-terminal ligand-binding domain (LBD; E domain). The LBD contains the hormone binding pocket, the major dimerization interface and a hormonedependent transactivation function, called AF2. Like the C domain, the E domain is evolutionarily conserved among the receptors (Laudet 1997) . On the basis of this domain organization, and significant sequence conservation, a large number of so-called orphan receptors have been characterized (Enmark & Gustafsson 1996) . These members of the superfamily contain the same domains as the liganded receptors, but the identity of their ligand is still unknown. In fact, it is unclear whether these receptors are regulated by a ligand still to be identified or whether they are true orphans that are regulated by mechanisms other than ligand binding (Escriva et al. 2000) .
The intracellular localization of nuclear receptors is the result of a dynamic equilibrium of cytoplasmic-nuclear shuttling as demonstrated for the progesterone receptor (PR, NR3C3) and the glucocorticoid receptor (GR, NR3C1) (GuiochonMantel et al. 1991 , Madan & DeFranco 1993 . Nuclear translocation of cytoplasmic receptors is due to the presence of short sequences rich in basic amino acids, called nuclear localization signals (NLSs) . NLSs are most often located in the junction between the C and D domains, in the D domain or in the E domain (Laudet & Gronemeyer 2002) . NLSs located in the E domain are liganddependent but their precise location and sequence remain unknown. Studies on the subcellular localization of unliganded receptors indicate three categories: exclusively cytoplasmic receptors like GR and androgen receptor (AR, NR3C4) (Htun et al. 1996 , Georget et al. 1998 , both cytoplasmic and nuclear receptors like mineralocorticoid receptor (MR, NR3C2) and TR (NR1A2) (Fejes-Toth et al. 1998 , Zhu et al. 1998 , and exclusively nuclear receptors like oestrogen receptor (ER , NR3A1) and PR (GuiochonMantel et al. 1989 , Lim et al. 1999 , although in some cases this issue remains controversial. All receptors located in the cytoplasm in the unliganded (apo-) form translocate into the nucleus upon ligand binding (Htun et al. 1996 , Fejes-Toth et al. 1998 , Georget et al. 1998 , Zhu et al. 1998 , Lim et al. 1999 . Unliganded receptors that are located in cytoplasm, such as GR, AR and TR , have in common the position of their NLS in the T and A boxes just downstream of the C domain (Picard & Yamamoto 1987 , Zhou et al. 1994 , Zhu et al. 1998 ). These boxes have been shown to play an important part in DNA binding and dimer formation (Laudet & Gronemeyer 2002) . It is believed that, in such a position, the NLS is exposed by the conformational changes induced in the LBD upon ligand binding, and becomes accessible to the nuclear translocation machinery. In contrast, ER and PR, apo-forms located in the nucleus, have three proto-NLSs located in the C and D domains (Guiochon-Mantel et al. 1989 , Ylikomi et al. 1992 . These NLSs function cooperatively, because the association between two or three proto-NLSs is required to translocate the receptor to the nucleus.
The Rev-erb group of orphan receptors contains two mammalian members, Rev-erb (NR1D1) and Rev-erb (NR1D2), and one from Drosophila, the ecdysone-regulated gene E75 (NR1D3) (Lazar et al. 1989 , Miyajima et al. 1989 , Segraves & Hogness 1990 , Laudet et al. 1991 , Bonnelye et al. 1994 , Dumas et al. 1994 , Enmark et al. 1994 , Retnakaran et al. 1994 . The founding member of this group, Rev-erb , was discovered as a gene transcribed on the non-coding strand of the c-erbA-1 protooncogene that encodes TR (NR1A1) (Lazar et al. 1989 , Miyajima et al. 1989 , Laudet et al. 1991 . Rev-erb receptors are closely related to the ROR (NR1F) group of nuclear receptors, which contains three genes, , and (NR1F1-3), and a unique homologue in Drosophila, called DHR3 (NR1F4) (Koelle et al. 1992 , Carlberg et al. 1994 , Hirose et al. 1994 . ROR and Rev-erb share 58% and 37% identical amino acids in the C and E domains respectively. Rev-erbs have no known ligand, lack the AF2-activating domain (AF2-AD) region that is necessary for coactivator binding, bind to DNA as monomers or homodimers, and constitutively repress transcription when bound on their responsive element, known as RevRE (recognized by the monomeric form) or RevDR2 (bound by the homodimer) (Harding & Lazar 1995 , Adelmant et al. 1996 , Renaud et al. 2000 . In contrast to Rev-erbs, ROR orphan receptors act as constitutive transcriptional activators in the absence of exogenously added ligand through monomeric DNA response elements that are extremely similar to the RevRE. In a given cell, the amount of activity emanating from a RevRE is the result of a balance between activation by ROR and repression by Rev-erb proteins. Little is known about Rev-erb functions in vivo. Rev-erb gene expression is induced during adipocyte differentiation, is downregulated during muscle differentiation, and is under circadian regulation in adult rat liver and during development in the zebrafish (Chawla & Lazar 1993 , Balsalobre et al. 1998 , Downes et al. 1995 . Rev-erb represses transcription of the apolipoprotein A1 (ApoA1) and hydratase dehydrogenase genes, suggesting a role of this orphan receptor in metabolic control (Vu-Dac et al. 1998 , Kassam et al. 1999 . In accordance with this notion, we have shown that fibrates, commonly used hypolipidaemic drugs, decrease ApoA1 concentrations through induction of Rev-erb gene expression in liver (Gervois et al. 1999) .
To date, most studies dealing with NLS in nuclear receptors have been devoted to liganded receptors, and there are only a very few reports on NLS location in orphan receptors (Hager et al. 2000 , Laudet & Gronemeyer 2002 . In an attempt to gain better understanding of the mode of action of Rev-erb gene products, we decided to characterize the proteins encoded by these genes. Given a possible role in circadian rhythms, we first concentrated on the location of the Rev-erb NLS, because it has been shown that nuclear entry of proteins that are part of the circadian oscillator is tightly regulated (Lee et al. 2001) . To analyse the subcellular distribution of Rev-erb proteins, we generated polyclonal antibodies that were able specifically to recognize Rev-erb or Rev-erb . Using transient transfection assays and green fluorescent protein (GFP) fusion proteins, we mapped Rev-erb NLS within the DBD and we showed that two basic amino acids located just upstream of the second zinc finger have a critical role in this NLS. Surprisingly, this NLS is not conserved in the closely related ROR orphan receptors.
Materials and methods
Expression of Rev-erb fragment in bacteria, and generation of rabbit sera
The appropriate fragments were obtained from Rev-erb and Rev-erb encoding cDNAs as templates in polymerase chain reaction (PCR) experiments using oligonucleotides containing either a BamHI restriction site (5 oligo) or a HindIII site (3 oligo). These fragments were introduced in a pLC24-derived vector linearized with BamHI and HindIII. The sub-cloning resulted in the in-frame fusion of the desired sequence to the first 99 amino acids of the RNA polymerase of phage MS2.
The oligonucleotides used to amplify the region of the chicken (ck) Rev-erb DBD were as follows: 5 primer: 5 -TAG GGA TCC CAA TAG AAA CAG ATG CCA G; 3 primer: 5 -ATC AAG CTT ACA TGG CAC TCT GCA TTT C. This fragment contains the region coding for 43 amino acids from position 127 to position 170 of the ckRev-erb protein. As this region is highly conserved between Rev-erb proteins, it generated a serum able to recognize both Rev-erb and (hence its name, AB43). The oligonucleotides used to amplify the region of human (h) Rev-erb LBD in order to generate a Rev-erb -specific serum (called A83) were as follows: 5 primer: 5 -TAG GGA TCC CCG GCA GGG CAA CTC AAA G; 3 primer: 5 -ATC AAG CTT ACA CGT TGA ACA ACG AAG C. This fragment contains the region coding for 83 amino acids of the LBD of hRev-erb from position 407 to position 490. The oligonucleotides used to amplify the region of ckRev-erb LBD in order to generate a Rev-erbspecific serum (called B81) were as follows: 5 primer: 5 -TAG GGA TCC CAA CAC TGG AGG AAG AAT G; 3 primer: 5 -ATC AAG CTT ATG CAT CAA ACA AAG ATG C. This fragment contains the region coding for 81 amino acids of the LBD of ckRev-erb from position 345 to position 426. The A83 and B81 peptides correspond to homologous regions in the two proteins and their conservation across species made it possible to obtain isoform-specific serum that can recognize either Rev-erb or Rev-erb proteins from several species.
For expression, plasmids grown in LE392( ) were transferred into an Escherichia coli host (SG4044) that has a temperature-sensitive repressor of the pL promoter. Cultures of exponentially growing bacteria carrying the desired vector were incubated at 42 C for 3 h. Bacterial pellets were washed twice, boiled in sample buffer, and electrophoresed on an SDS-15% polyacrylamide gel. Proteins were visualized by staining with Coomassie brilliant blue and cut from the gel. Rabbit antisera were prepared from these proteins.
The preimmune sera were obtained before immunization. The adsorbed sera were adsorbed on the fusion protein against which they were raised. The specific A83 serum, A83 Spe, corresponds to the A83 serum adsorbed against the fusion protein MS2-B81 because, as indicated above, the A83 and B81 peptides were derived from homologous regions of the two proteins. In the same way, the specific B81 serum, B81 Spe, corresponds to the B81 serum adsorbed against the fusion protein MS2-A83.
Plasmids for immunofluorescence
The appropriate fragments used for immunofluorescence were obtained from pSG5 hReverb expression vector by PCR experiments using oligonucleotides containing a 5 HindIII restriction site and start codon, and a 3 BamHI restriction site and stop codon. The expected bands were subjected to HindIII-BamHI restriction enzyme digestion and inserted between the HindIII and BamHI sites of pSG5. Oligonucleotide sequences are available from author V L upon request.
GFP chimeras
The appropriate fragments used to construct the GFP chimeras were obtained from pSG5 hReverb -, pSG5 ckRev-erb -, pCMXhROR -and pCMXROR -encoding cDNAs by PCR experiments using oligonucleotides containing a 5 HindIII restriction site and a 3 BamHI restriction site. The expected bands were subjected to HindIII-BamHI digestion and inserted between the HindIII and BamHI sites of pEGFP-C1 (Clontech). The sub-cloning resulted in the in-frame fusion of the desired sequence to the C-terminal part of the first 238 amino acids of the GFP. All GFP constructs were checked by sequencing. Oligonucleotide sequences are available from author V L upon request.
In vitro translation and immunoprecipitation
Methionine-labelled hRev-erb and ckRev-erb proteins were synthesized in cell-free conditions using the rabbit reticulocyte lysate system (Promega) according to the manufacturer's recommendations. The synthesized proteins were tested on 10% SDS-polyacrylamide gel or were incubated with polyclonal antibody overnight at 4 C in radioimmunoassay modified buffer (RIPA) buffer (20 mM Tris, pH 7·5, 150 mM sodium chloride, 2 mM EDTA, 1% (wt/vol) sodium deoxycholate, 1% (vol/vol) Triton X-100, 0·25% (wt/vol) SDS). Immune complexes were collected using protein A-sepharose (Pharmacia) and washed six times in RIPA buffer. Protein complexes were separated on 10% SDS-polyacrylamide gels. Gels were dried and exposed to Hyper film (Amersham).
Immunofluorescence and GFP chimera analysis
COS-1 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum.
Plasmid DNAs were transiently transfected in cells using PEI (Euromedex, Mundolsheim, France) according to the supplier's instructions. COS-1 cells transfected with the relevant pSG5 construct were fixed, 48 h after transfection, in 4% paraformaldehyde in PBS for 20 min. The cells were permeabilized with 0·15% Triton X-100 in PBS for 2 min. After treatment with 1% ethanolamine in PBS for 20 min at 4 C, the sera were diluted at 1/100 in 0·5% bovine serum albumin and incubated for 1 h at 37 C with the fixed cells. The anti-Rev-erb immunoreactive proteins were detected with fluorescein isothiocyanate goat antirabbit immunoglobulins (Dako, Trappes, France) secondary reagent. For localization of GFP fusion proteins, transfected COS-1 cells were fixed 48 h after the transfection in 2% paraformaldehyde, 0·2% glutaraldehyde in PBS. The cells were observed using an epifluorescence microscope (Axiovert 135 TV, Zeiss) with specific filters. In each experiment, 300 cells were counted, and each experiment was performed three times.
Results

Production of polyclonal antibodies against Rev-erb proteins
To study the Rev-erb proteins, we decided to produce polyclonal antibodies with different specificities: one that specifically recognizes Rev-erb proteins from several species, another that specifically recognizes Rev-erb proteins, and one that may recognize both Rev-erb and Rev-erb . With this aim, we generated several fusion proteins containing various regions of the Rev-erb proteins. We took advantage of the fact that Rev-erb and Rev-erb proteins share 97% identity in their DBD, and 68% in their LBD. To obtain a serum able to recognize both Rev-erb and Rev-erb , we used a 43 amino acid fragment located in the C-terminal part of the Rev-erb DBD (Fig. 1a) , which is highly conserved between both paralogous gene products. Using this fragment, we generated the AB43 serum in order to label both Rev-erb and Rev-erb . To obtain a Rev-erb -specific serum, called A83, we targeted an 83 amino acid region of the LBD (Fig. 1a) , which is different from the corresponding Rev-erb region, but well conserved among the various known Rev-erb proteins. The homologous region of Rev-erb was used to generate the B81 serum in order to recognize the Rev-erb protein specifically (Fig. 1a) .
We tested the ability of the AB43 serum specifically to recognize Rev-erb proteins using whole [
35 S]methionine-labelled hRev-erb or ckRev-erb expressed in reticulocyte lysates (Fig.  1b , lanes 13 and 14: labelled proteins produced by the reticulocyte lysate system). Using immunoprecipitation experiments, we obtained proteins of the expected size (68 kDa and 60 kDa for Rev-erb and Rev-erb respectively; lanes 3 and 4) that were not recognized by the preimmune (Pi; lanes 1 and 2) or the adsorbed sera (Ads, lanes 5 and 6). We verified that this serum was unable to cross-react with the closely related ROR and ROR (data not shown). We conclude from these experiments that the AB43 antibody is able to recognize both Rev-erb and Rev-erb .
Using the same approach, we characterized the specific sera A83 (Fig. 1b) and B81 (not shown).
The A83 serum recognized mainly the Rev-erb protein, but weakly the Rev-erb protein (Fig. 1b,  lanes 9 and 10) . This was not surprising, because The localization of the fragments that were used, fused to the MS2 polymerase for immunization, is shown in the diagram. These fragments were located in the N-terminal part of the LBD (hatched box) of Rev-erbα (A83 serum), the N-part of the LBD of Rev-erbβ (B81 serum) and the junction between the DBD (grey box) and the hinge domain that is conserved between Rev-erbα and β (AB43 serum). The T/A box and the functional domains are also indicated. (b) Characterization of the antisera directed against Rev-erbα and Rev-erbβ proteins. The Rev-erbα and Rev-erbβ cDNA were transcribed and translated in vitro using rabbit reticulocyte lysate (right-hand panel). Translated proteins were immunoprecipitated with rabbit antisera prepared against bacterially expressed peptides. The sera AB43 (left) or A83 (middle) were used to immunoprecipitate the in vitro-produced proteins, either Rev-erbα (α lysate) or Rev-erbβ (β lysate). Pi, serum from preimmune rabbits; Ads, serum from immunized rabbits and adsorbed against the peptide, used for immunization (MS2-AB43 for the left panel and MS2-A83 for the middle panel); I, serum from immunized rabbits; Spe, serum from immunized rabbits and adsorbed against the MS2-B81 fusion protein.
the two proteins share a high level of identical amino acids in the region used for immunization and thus probably have common epitopes. The A83 preimmune serum or the A83 serum adsorbed against the MS2-A83 protein did not recognize the hRev-erb protein (Fig. 1b, lanes 7 and 8) . In order to generate a reagent that was able to recognize Rev-erb , but not Rev-erb , the A83 serum was adsorbed against the fusion protein MS2-B81. This procedure was aimed not only at neutralizing antibodies that recognized commons epitopes of MS2-A83 and MS2-B81, but also at eliminating MS2 cross-reactivity. The serum was called 'A83-specific serum' (A83 Spe) and it recognized only the Rev-erb protein, and not Rev-erb (Fig 1b, lanes 11 and 12) . Thus the A83 Spe serum specifically recognized Rev-erb . Using the same strategy, a serum that specifically recognized Rev-erb but not Rev-erb was also generated and called 'B81 Spe' (data not shown).
These results obtained using the in vitrotranslated Rev-erb proteins were confirmed by immunoprecipitation of lysates from COS-1 cells transfected with Rev-erb or Rev-erb expression vectors (data not shown). These sera also were able to recognize both Rev-erb proteins present in transfected COS-1 cells using western blotting. We were also able to visualize endogenous Rev-erb proteins from a variety of human and chicken cell lines using AB43, A83 or B81 serum (not shown). We conclude that the A83 Spe and B81 Spe sera specifically recognize Rev-erb and Rev-erb , respectively, and that the AB43 serum recognizes the two proteins.
Nuclear localization of Rev-erb and Rev-erb
To examine the cellular localization of Rev-erb proteins, COS-1 cells were transfected with expression vectors for Rev-erb or Rev-erb proteins, and their subcellular localization was assayed by immunofluorescence with the AB43 serum on fixed COS-1 cells (Fig. 2) . Using this serum, we observed a specific signal in the nucleus of cells transfected with either a pSG5-Rev-erb (Fig. 2c) or a pSG5-Rev-erb (Fig. 2d ) expression vector. No staining was visualized with the preimmune AB43 serum (Fig. 2a , and data not shown). Similarly, no staining was observed in cells transfected with the control vector pSG5 (Fig. 2b) . These experiments clearly show that, in the context of transiently transfected COS-1 cells, both Rev-erb and Rev-erb are nuclear proteins.
Because Rev-erbs are large proteins, they need an active translocation machinery that recognizes their NLS in order to enter the nucleus. To map the Rev-erb NLS, we used immunofluorescence to test the localization of several deletion mutants of Rev-erb (Fig. 3) . The 1-236 deletion mutant contains the A/B and C domains in addition to a small part of the hinge region, whereas the 236-614 deletion mutant contains the D and E domains (Fig. 3a) . In these experiments, the wild-type Rev-erb was localized exclusively in the nucleus in 81% of the transfected cells, and was localized in both nucleus and cytoplasm in 19% of the cells. Like the full-size protein, the 1-236 mutant was exclusively nuclear in a large majority of the cells (70%) and was present in both nucleus and cytoplasm for the remaining 30% (Fig. 3a, b) . In contrast, the 236-614 mutant was cytoplasmic in 100% of the transfected cells (Fig. 3a, b) . This finding was confirmed by the analysis of several C-terminal deletion mutants, all of which were found in the cytoplasm (Fig. 3a) . This deletional mutant approach suggests that no cryptic NLS is located in the E domain of Rev-erb .
As the percentage of cells exhibiting exclusively nuclear staining seemed to be lower for the 1-236 mutant than for the full-size protein, and because, in many instances, the NLS of nuclear receptors is located in the D domain, we checked whether we might have disrupted a NLS signal by creating the different deletional mutants. To test this hypothesis, we generated another N-terminal Rev-erb mutant, the 1-288 protein, which extends further into the D domain. Like the 1-236 protein, the 1-288 mutant was exclusively nuclear in 68% of the stained cells, and localized in both nucleus and cytoplasm in 32% of the cells (Fig. 3a) .
The Rev-erb gene encodes two N-terminal isoforms: the major one, Rev-erb 1, is 614 amino acids long and the second one, Rev-erb 2, is generated from an internal promoter and translated from an internal ATG codon located at position 107 within the A/B region of Reverb 1 (G. Triqueneaux et al., unpublished observations) . Like Rev-erb 1, the Rev-erb 2 protein was predominantly nuclear when transiently transfected into COS-1 cells, suggesting that the NLS is not located within the first 107 amino acids of the Rev-erb 1 protein (Fig. 3a) . This was further confirmed by the analysis of several N-terminal truncations of the 1-236 construct that also exhibited nuclear localization (Fig. 3a) . The lower number of cells exhibiting exclusive nuclear staining in this experiment is likely to be due to the small size of mutant proteins (from 24 to 18 kDa), because it is known that small proteins (<30 kDa) can pass across the nuclear membrane to the cytoplasm by simple diffusion. Taken together, these data suggest that the Rev-erb NLS is located in the N-terminal part of the protein between positions 107 and 236.
The NLS of Rev-erb proteins is located in the C domain
Next, we used a GFP technique in order to map precisely the NLS of Rev-erb . Indeed, tagging nuclear receptors with GFP allows direct visualization of these receptors inside the cells, without exogenous substrates or cofactors. GFP was a cytoplasmic protein in the context of transiently transfected COS-1 cells (Fig. 4a) ; this makes it possible to determine the precise location of the Rev-erb region that will target GFP into the nucleus. The fusion of the 1-236 region of Rev-erb to the C-terminal part of GFP generated a chimera (GFP/1-236) that showed a nuclear localization (Fig. 4b) , confirming the results presented above. According to the nuclear localization of Rev-erb 2, the GFP/1-107 chimera exhibited a nucleocytoplasmic localization (Fig. 4c) , whereas the GFP/107-236 protein remained nuclear (Fig. 4d) .
These results suggest that the major Rev-erb NLS is located in the DBD. This region contains the T and A boxes in the N-terminal region of the D domain (position 198-226 of hRev-erb ). As Figure 3 The major Rev-erbα NLS is located in the 107-236 region. (a) Structure and subcellular localization of Rev-erbα deletion mutants. The structure of the full-length hRev-erbα1 protein (1-614) is depicted, with its various functional domains. Grey boxes correspond to the DBD, and hatched boxes to the LBD. The T and A boxes in the hinge domain are shown. The AB43 serum (for the 1-236 construct and its derivatives) and the A83 Spe serum (for the 236-614 construct and its derivatives) were used to assay the subcellular localization of Rev-erbα deletion mutants and Rev-erbα2 (107-614) by immunofluorescence on transfected fixed COS-1 cells. In each case, the localization and the proportion of cells exhibiting a given subcellular localization of the protein is indicated: N, nuclear; C, cytoplasmic; N/C, nuclear and cytoplasmic. The 236-614 proteins and the C-terminal deletion mutants are exclusively cytoplasmic for 100% of the transfected cells. (b) The location of the proteins was studied by immunofluorescence on transiently transfected COS-1 cells. The location of the protein encoded by the pSG5-Rev-erbα1-236 (left) and pSG5-Rev-erbα236-614 (right) vectors was studied using the AB43 and A83 Spe antisera respectively. the T and A boxes of TR and AR are known to contain an NLS (Zhou et al. 1994 , Zhu et al. 1998 , and this region of Rev-erb is rich in basic amino acids that are often parts of NLSs in general (LaCasse & Lefebvre 1995), we tested whether the T and A boxes of Rev-erb could target GFP to the nucleus. Surprisingly, the GFP/198-226 chimera, which contains the T and A boxes of the hRev-erb protein, exhibited a nucleocytoplasmic localization (Fig. 4e) . Consistent with this observation, the GFP/128-191 mutant containing only the C domain with its two zinc fingers showed strong and clear nuclear staining (Fig. 4f) .
The location of the Rev-erb NLS in the C domain is specific
The C domain of Rev-erb and Rev-erb have 97% amino acid identity (Fig. 5a) . We thus determined whether Rev-erb protein presents the same particular NLS location as Rev-erb . To this end, we fused the corresponding region of Rev-erb to GFP (GFP/DBD.Rev-erb ) and transfected this construct into COS-1 cells. The resulting chimera protein clearly showed a strong nuclear localization (Fig. 5b, panels a and b) . Given this, we decided to test if this finding could be extended to the closely related ROR orphan receptors that exhibit 58% amino acid identity within the C domain. Using the same approach, we generated GFP/DBD.ROR and GFP/ DBD.ROR constructs that were introduced into COS-1 cells. We observed that in both cases the fusion proteins remained cytoplasmic (Fig. 5b , panels c and d). This surprising result suggests that the location of an NLS inside the C domain is specific for Rev-erb and Rev-erb proteins, and that the NLS for ROR proteins is located in other regions of the protein.
The high amino acid conservation between the C domain of Rev-erb and ROR proteins and the three-dimensional structure of the Rev-erb /DNA complex determined by X-ray crystallography (Zhao et al. 1998, and Fig. 5c ) allowed us to predict amino acids that may be critical for this NLS, as these amino acids should be accessible residues not conserved in ROR proteins. An alignment of hRev-erb and ROR amino acid sequences thus suggested that the two basic residues, Lys 167 and Arg 168 (A135 and A136 respectively, in the three-dimensional structure from Zhao et al. 1998) , of the Rev-erb DBD and not present in ROR, could be important for interactions with the nuclear transport machinery. As shown in Fig. 5c , these two polar residues are localized in the loop region linking the two zinc finger domains, which is well exposed at the monomer protein surface.
In order to test this assumption, the two putative residues of the Rev-erb DBD were substituted with their ROR counterparts (see alignment in Fig. 5a ). The introduction of the resulting GFP fusion protein, GFP/DBDm. Rev-erb (*S), in COS-1 cells clearly demonstrated the importance -107 (c), 107-236 (d), 198-226 (e) and 128-191 (f) . In each case the functional domains are shown schematically above the picture. of these two polar residues, because their mutation impaired the nuclear localization of the GFP/ DBD.Rev-erb fusion protein (Fig. 5b, panel e) . Introduction of the two basic amino acids K167 and R168 from Rev-erb into an ROR DBD, DBDm.ROR (KR), rendered this domain able to target GFP protein into the nucleus (Fig. 5b, panel  f) , showing that these two amino acids were sufficient for nuclear targeting. These striking data demonstrate that residues K167 and R168 are critical structural determinants for Rev-erb protein targeting to the nucleus.
Discussion
In the present report we examined the subcellular localization of Rev-erb proteins. Our results, obtained in immunofluorescence studies, demonstrate that both Rev-erb and Rev-erb were nuclear in transfected COS-1 cells. The GFP fusion protein technique allowed us to demonstrate that the major NLS of Rev-erb and Rev-erb is in the DBD and, more precisely, in the zinc finger region, and unlike other nuclear receptors, no NLS is present within the LBD. The corresponding regions of ROR and ROR do not contain such NLSs. The structural comparison between Reverb and ROR in this region identified two residues, K167 and R168, that are critical for the nuclear localization of Rev-erb . Strikingly, the introduction of these two residues in the ROR DBD in the context of a GFP fusion protein allowed this protein to enter the nucleus.
The absence of any NLS in the Rev-erb E domain is surprising, given that many liganded receptors such as GR and ER have an NLS in this region (Picard & Yamamoto 1987 , Ylikomi et al. 1992 . We are confident that the cytoplasmic localization of the 236-614 mutant is not an artefact, because a comparable result was also found with a series of C-terminal deletions of this domain. As the subcellular location of the 236-614 protein was studied with a different serum (namely A83) than AB43 and was able to recognize the Rev-erb N-terminal region, one might argue that the A83 serum may be unable to detect proteins in the nucleus. However, with both the A83 Spe serum and AB43 serum, we consistently observed a nuclear localization of the full-length Rev-erb protein, with identical proportions between nuclear and cytoplasmic labelling (data not shown). Hence, the A83 Spe serum is able to enter the nucleus and to recognize the Rev-erb protein in this environment. Interestingly, the NLSs that have been found in the LBD of nuclear receptors have, to date, been described only for liganded receptors, such as GR and ER , and have been found to be ligand-dependent (Picard & Yamamoto 1987 , Ylikomi et al. 1992 . It seems that these NLSs are hidden and not available for the nuclear transport complex in the apo-form of the receptor. As ligand binding promotes a conformational change in the LBD of these receptors, one might expect that, upon such changes, the LBD -and NLS -are thus exposed and available for nuclear transport. Because modelling of the three-dimensional structure of the Rev-erb LBD suggests that this receptor is a true orphan with no available ligand binding pocket (Renaud et al. 2000) , we cannot exclude the possibility that the LBD includes a cryptic NLS that is never exposed to the nuclear transport apparatus. Nevertheless, the fact that several C-terminal mutants of the Rev-erb LBD remain in the cytoplasm argues against such a possibility.
Nuclear localization signals have been mapped in the region encompassing the T and A boxes of numerous liganded receptors such as GR, TR , TR , AR, ER and PR (Picard & Yamamoto 1987 , Guiochon-Mantel et al. 1989 , Ylikomi et al. 1992 , Lee & Mahdavi 1993 , Zhou et al. 1994 , Zhu et al. 1998 . The corresponding region of Rev-erb , when fused to GFP, did not target the fusion protein to the nucleus. This suggests that the NLS of Rev-erb proteins is not in this region. Further experiments revealed that the NLS of Rev-erb is located in the zinc finger region. For the closely related ROR orphan receptors, the NLSs do not locate in the same region, but can be found there in two other unrelated orphan receptors, TR2 (NR2C1) and SF-1 (NR5A1) (Yu et al. 1998 , Hammer et al. 1999 . In fact, it has been shown that in 75% of known transcription factors, the NLS is located within or near (10 amino acids around) the DBD (Hager et al. 2000 , Laudet & Gronemeyer 2002 . For example, the transcription factor ETS-1 or the homeobox protein PDX-1 have their NLS in their DBD (Boulukos et al. 1989 , Hessabi et al. 1999 . The proximity of these two functions appears to be independent of both the type of DBD (zinc fingers, homeodomain, helix-loop-helix, etc.) and the type of NLS. Thus the situation observed for Rev-erb and for at least two other orphan receptors, TR2 and SF-1, could be the rule rather than the exception. Indeed, the fact that the NLSs of nuclear receptors often include the T and A boxes, which play an important part in DNA binding, supports this notion. It is conceivable that the location of the NLS outside the DBD, which was observed for liganded receptors such as GR and ER , may be linked to ligand-dependent nuclear localization, which induces an unmasking of a cryptic NLS function. Interestingly, the DBD has recently been shown to contain a nuclear export signal, which is conserved between most nuclear receptors (Tyagi et al. 1998 , Black et al. 2001 .
One remarkable observation of our study is that the mutation of only two amino acids within the ROR DBD can induce a nuclear translocation of this domain fused to the GFP protein. In general, two amino acids are not sufficient to establish an independent NLS (LaCasse & Lefebvre 1995) . This suggests that a proto-NLS exists in this region of ROR and that the addition of two basic amino acids is sufficient to reveal this function. Comparison of Rev-erb and ROR DBD indicates two structurally different regions: (i) the first zinc finger loop (positions 134-148 in hRev-erb ), and (ii) between the end of 1 helix and the D box in Figure 6 Alignment of the DBD of several nuclear receptors. This alignment shows that the basic character of the region upstream of the D-box is not conserved in all the superfamily members. Asterisks (*) indicates gaps. Accession numbers of the corresponding sequences can be found in Laudet & Gronemeyer (2002) . The official nomenclature of each receptor (Nuclear Receptors Nomenclature Committee 1999) is indicated.
